pristinamycin

ApprovedSmall molecule

Sanofi

pristinamycin is one of 44 small molecule programs targeting Pneumonia. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumoniaActive, not recruiting

TonsillitisActive, not recruiting

PneumoniaApproved

Active, not recruiting

TonsillitisPhase 3

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

pristinamycin

Sanofi

Approved

1 2

Primaxin

Pfizer

Preclinical

2 3

Prevacid

Takeda

Preclinical

1 4

Innohep

Alnylam Pharmaceuticals

Preclinical

1 5

Acanya

Pfizer

Preclinical

1 6

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

12 7

Zantac 150

CChattem

Preclinical

2 8

Gantanol

CConrado Roberto Hoffmann Filho

Preclinical

2 9

Mucinex

AAultman Health Foundation

Preclinical

1 10

Ofev

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pneumonia1 trial

Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Terminated· Sanofi logo

Sanofi·Phase 4·NCT02332577·161 enrolled

Tonsillitis1 trial

Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children

Completed· Sanofi logo

Sanofi·Phase 3·NCT00393744·395 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for pristinamycin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — pristinamycin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for pristinamycin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Sanofi

pristinamycin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pneumonia1 trial

Tonsillitis1 trial

References

Drug Info

Quick Facts

Related News